Articles From: UPDATE: 10 things the military won't tell you to Alnylam Introduces Pipeline Growth Strategy for RNAi Therapeutics in Three Strategic Therapeutic Areas, or “STArs”


2014/12/13
By Quentin Fottrell, MarketWatch 1.
Sign-up for UPDATE: 10 things the military won't tell you investment picks
2014/12/13
Once upon a time -- about half-a-century ago --
Sign-up for UPDATE: 10 things the military won't tell you -2- investment picks
2014/12/13
Even after a long, decorated career, many vets find it hard to find jobs that match their skills and education.
Sign-up for UPDATE: 10 things the military won't tell you -3- investment picks
2014/12/13
By Amy Hoak, MarketWatch Live the pirate's life in the U.S. Virgin Islands, or consider these other unusual homes For anyone who's ever dreamed of living the life of a storybook pirate--and has millions of dollars to spare--take a look at this home on the western tip of St.
Sign-up for UPDATE: 7 wacky mansions for sale investment picks
2014/12/13
Some companies are trying to help consumers avoid baggage fees by selling items you can wear on the plane (so you don't have to check an extra bag) that also carry a bunch of stuff.
Sign-up for UPDATE: 9 secrets for outsmarting airline -2- investment picks
2014/12/13
By Catey Hill, MarketWatch The airlines rake in more loot from checking one bag than many people do in an hour of hard work.
Sign-up for UPDATE: 9 secrets for outsmarting airline baggage fees investment picks
By Catey Hill, MarketWatch Haggling makes a comeback Fixed prices may be dying a slow death -- at least online -- as more retailers are letting us haggle with them to score a lower price.
Sign-up for UPDATE: Consumers may soon be shopping like it's 1899 investment picks
2014/12/13
By Priya Anand, MarketWatch Websites that play matchmaker for people who want to borrow money and those who have spare cash to lend, offer investors an enticing deal: Sweet returns and the chance to hand-pick who you trust to pay you back.
Sign-up for UPDATE: Should you give strangers your money on LendingClub? investment picks
2014/12/13
By Quentin Fottrell, MarketWatch When lonely people go shopping this holiday season, they'll likely get more satisfaction from cult-like and quirky items --
Sign-up for UPDATE: Spending money on these things may make you happier investment picks
2014/12/13
By Quentin Fottrell, MarketWatch You don't need to offend North Korean leader Kim Jong Un for your work emails to go public.
Sign-up for UPDATE: Why Sony's email leaks could happen to you investment picks
A.M. Best has affirmed the financial strength rating of A- (Excellent) and the issuer credit rating (ICR) of “a-” of Employers Insurance Company of Nevada , Employers Compensation Insurance Company , Employers Assurance Company and Employers Preferred Insurance Company , collectively referred to as the Employers Insurance Group .
Sign-up for A.M. Best Affirms Ratings of Employers Holdings, Inc. and Its Subsidiaries investment picks
A.M. Best has commented that the financial strength rating (FSR) of A- (Excellent) and the issuer credit ratings (ICR) of “a-” of the property/casualty subsidiaries ( collectively referred to as Kemper Property and Casualty Group) of Kemper Corporation (Kemper Corp.) [NYSE:KMPR] are unchanged following the announcement that Kemper Corp.
Sign-up for A.M. Best Comments on the Ratings of Kemper Corporation and Subsidiaries Following Acquisition Announcement investment picks
Abbott Declares 364th Consecutive Quarterly Dividend ABBOTT PARK, Ill., Dec.
Sign-up for Abbott Announces Increase in Quarterly Dividend investment picks
ABBOTT PARK, Ill., Dec.
Sign-up for Abbott Completes Acquisition of Veropharm investment picks
2014/12/12
TIDMABT RNS Number : 6021Z Abbott Laboratories 12 December 2014 Abbott Completes Acquisition of Veropharm ABBOTT PARK, Ill., Dec.
Sign-up for Abbott Laboratories Acquisition investment picks
Abbott (ABT) said Friday it is raising its quarterly dividend to 24 cents a share from 22 cents.
Sign-up for Abbott raises quarterly dividend to 24 cents a share from 22 cents investment picks
2014/12/12
The total investment in the project is US$ 640 million, to be developed in a 3-year construction term and a 22-year operation period.
Sign-up for Abengoa Completes Its Non Recourse Long Term Financing for the El Zapotillo Aqueduct in Mexico investment picks
2014/12/12
Acadia Realty Trust (NYSE: AKR - "Acadia" or the "Company") today announced that it expects to receive approximately $108.0 million in estimated gross proceeds from its sale of 3,400,000 common shares of beneficial interest (“Shares”) to Citigroup (or approximately $124.1 million if the option to purchase additional Shares is exercised in full). Citigroup acted as the sole bookrunner for the offering.
Sign-up for Acadia Realty Trust Announces Pricing of 3.4 Million Common Share Offering investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced the appointment of Francois Nader, M.D., M.B.A, to its Board of Directors.
Sign-up for Acceleron Pharma Appoints Dr. Francois Nader to its Board of Directors investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Actuate Corp.
Sign-up for ACTUATE CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Actuate Corp. Over the Proposed Sale of the Company to Open Text Corp. - BIRT investment picks
2014/12/12
By MarketWatch, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Friday's session are Adobe Systems Inc., Priceline Group Inc., and Quiksilver Inc. Adobe(ADBE) late Thursday reported fiscal fourth-quarter net income of $73.3 million, or 14 cents a share, up from $65.3 million, or 13 cents a share, in the year-earlier period.
Sign-up for Adobe, Priceline, Quiksilver in spotlight investment picks
PRINCETON, N.J., Dec.
Sign-up for Advaxis's Cancer Immunotherapies Featured on FOX News investment picks
2014/12/12
Air Canada Launches Year-Round Service to Rio de Janeiro Canada NewsWire Toronto global hub expansion continues with second Brazilian destination TORONTO , Dec.
Sign-up for Air Canada Launches Year-Round Service to Rio de Janeiro investment picks
The Board of Directors of Albany International Corp.
Sign-up for Albany International Declares Dividend investment picks
2014/12/12
Alexandre Bilodeau Voted Air Canada Athlete of the Year Canada NewsWire Canadian Olympic freestyle skier tops national poll for Air Canada Athlete of the Year Award MONTREAL , Dec.
Sign-up for Alexandre Bilodeau Voted Air Canada Athlete of the Year investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983764001&sourceType=1 http://media3.marketwire.com/docs/logo_ANV_200.jpg RENO, NEVADA --
Sign-up for Allied Nevada Announces Closing of Previously Announced Public Offering of Common Stock and Warrants investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today its pipeline growth strategy for development and commercialization of RNAi therapeutics across three Strategic Therapeutic Areas (STArs): Genetic Medicines, Cardio-metabolic Disease, and Hepatic Infectious Disease.
Sign-up for Alnylam Introduces Pipeline Growth Strategy for RNAi Therapeutics in Three Strategic Therapeutic Areas, or “STArs” investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: UPDATE: 10 things the military won't tell you to Alnylam Introduces Pipeline Growth Strategy for RNAi Therapeutics in Three Strategic Therapeutic Areas, or “STArs”
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent